Research | OneLook Acronym Finder |
Serial Number | 79975767 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | MATTHEW J. SMITH |
Law Office Assigned | L40 |
Employee Name | NUNLEY, CHRISTOPHER MI |
2021-08-04 | Application Filed |
2024-02-05 | Status: Live/Pending |
2024-02-09 | Location: DIVISIONAL UNIT |
2024-02-09 | Transaction Date |
Owner: | Dyad Artificial Intelligence Ltd |
Entity Statement | Limited Company |
Address | 86-90 Paul Street London EC2A 4NE GB |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
Type Code | Type |
---|---|
GS0091 | Downloadable and recorded computer software for database management, operation and coordination in the medical and pharmaceutical fields; downloadable and recorded computer platform software for database management, operation and coordination in the medical and pharmaceutical fields; downloadable and recorded computer database software for database management, operation and coordination in the medical and pharmaceutical fields; downloadable and recorded computer software for data analysis and reporting for use in the medical and pharmaceutical fields; downloadable and recorded application software for mobile phones for database management, operation and coordination; downloadable and recorded computer programs for database management, operation and coordination; downloadable and recorded computer software for research and development of pharmaceuticals for medical purposes; downloadable and recorded computer databases for database management, operation and coordination in the medical and pharmaceutical fields; computer database servers for use in the medical and pharmaceutical fields; downloadable and recorded computer software for database management for use in the medical and pharmaceutical fields; downloadable and recorded computer software for creating searchable databases of information and data for use in the medical and pharmaceutical fields; downloadable and recorded online electronic publications, namely, books, magazines, journals, manuals, brochures, articles and reports featuring data, results and information for use in the medical and pharmaceutical fields; none of the aforesaid relating to food and dietary supplements; none of the aforesaid for use in connection with interpreting and analyzing medical images |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-02-10 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-02-11 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-02-15 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-05-03 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-05-05 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-05-06 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2022-06-09 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-06-09 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2022-06-28 | 9 RFNT P: |
NEW REPRESENTATIVE AT IB RECEIVED | 2022-09-30 | 10 NREP P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-12-08 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-12-08 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-12-09 | 13 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2023-02-09 | 14 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2023-02-09 | 15 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2023-02-09 | 16 GNFN O:Outgoing Correspondence |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2023-07-12 | 17 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-07-12 | 18 OPNS P: |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2023-07-31 | 19 OPNX P: |
EXPARTE APPEAL RECEIVED AT TTAB | 2023-08-09 | 20 EXAF T:TTAB Proceeding |
JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2023-08-09 | 21 JURT T:TTAB Proceeding |
EX PARTE APPEAL-INSTITUTED | 2023-08-09 | 22 EXPI T:TTAB Proceeding |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-08-08 | 23 ERFR I:Incoming Correspondence |
ASSIGNED TO LIE | 2024-01-04 | 24 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-01-04 | 25 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-01-04 | 26 TEME I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2024-02-05 | 27 AITU A:Allowance for Publication |
ACTION CONTINUING FINAL - COMPLETED | 2024-02-05 | 28 CNCF S: |
ACTION DENYING REQ FOR RECON E-MAILED | 2024-02-05 | 29 GECD O:Outgoing Correspondence |
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | 2024-02-05 | 30 GEA1 O:Outgoing Correspondence |
DIVISIONAL REQUEST RECEIVED | 2023-08-09 | 31 DRRR I:Incoming Correspondence |
DIVISIONAL PROCESSING COMPLETE | 2024-02-09 | 32 DPCC D:Assigned to Examiner |
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED | 2024-02-13 | 33 MNDA O:Outgoing Correspondence |
EXPARTE APPEAL RECEIVED AT TTAB | 2024-02-15 | 34 EXAF T:TTAB Proceeding |
EX PARTE APPEAL-INSTITUTED | 2024-02-15 | 35 EXPI T:TTAB Proceeding |
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | 2024-04-26 | 36 EXFB T:TTAB Proceeding |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.